Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations

Springerplus. 2015 Sep 21:4:531. doi: 10.1186/s40064-015-1233-y. eCollection 2015.

Abstract

[This corrects the article DOI: 10.1186/s40064-015-0827-8.].

Publication types

  • Published Erratum